Role of biomarkers in guiding treatment with aldosterone-blocking agents

  • F. Zannad, J.-M. Ketelslegers, P. Bramlage
  • European Heart Journal Supplements, June 2011, Oxford University Press (OUP)
  • DOI: 10.1093/eurheartj/sur003

The authors haven't finished explaining this publication. If you are the author, sign in to claim or explain your work.

Read Publication

http://dx.doi.org/10.1093/eurheartj/sur003

The following have contributed to this page: Peter Bramlage